Understanding Research Studies on Canine Hepatocellular Carcinoma
Research studies can provide valuable information about canine hepatocellular carcinoma (HCC), including treatment outcomes, survival times, and other findings related to the disease.
Understanding how studies are designed, how results are reported, and what the limitations of studies may be can help you put those findings into context.
Published: March 30, 2026 | Last updated: August 18, 2026
Types of StudiesSample SizeMedian Survival TimeSurvival Times in ContextTreatment Outcomes in ContextTypes of Studies You May See
Research papers may use terms such as case report, case series, cohort study, randomized controlled trial, retrospective study, and prospective study when describing research. Being familiar with these terms can help you better understand how a study was designed and how its data was collected.
Retrospective Studies
In retrospective studies, researchers use patient data that was collected before the study began, such as information in existing medical records. The term retrospective describes the timing of data collection, not a specific study design. Because researchers did not oversee how the data was originally collected, retrospective studies may be more susceptible to bias and other factors that can complicate interpretation.Totten et al.
Prospective Studies
In prospective studies, researchers collect patient data after the study begins, although the events or outcomes being studied may have occurred earlier. The term prospective describes the timing of data collection, not a specific study design.Totten et al.
Case Reports
Case reports describe a single dog with a particular disease or condition. They can be useful for describing rare or novel diseases, unusual ways a disease presents, or diagnostic and treatment approaches. They may also provide ideas for further research.Sargeant et al., 2017 Because they describe an individual case, their findings may not apply broadly.
Case Series
Case series describe multiple dogs with a particular disease or condition and may report information about how the disease presents, disease progression, diagnosis, or prognosis. They can be useful for describing rare or novel diseases, unusual ways a disease presents, or diagnostic and treatment approaches. They may also provide ideas for further research. Because case series do not include a comparison group, they are limited in their ability to evaluate treatment efficacy or determine the significance of potential risk factors.Sargeant et al., 2017
Cohort Studies
Cohort studies follow a defined group of dogs over time to observe if a particular disease or outcome occurs. Cohort studies can be prospective or retrospective.Merck, Epidemiology
Randomized Controlled Trials
Randomized controlled trials compare outcomes between groups of dogs who are randomly assigned to a study group or a control group.Merck, Epidemiology
Understanding Randomized Controlled Trials
Randomized controlled trials (RCTs) are among the strongest forms of primary research for evaluating the effectiveness of treatments and other interventions.Sargeant et al., 2023
In randomized controlled trials:
- Dogs are selected for participation in the study.Merck, Epidemiology
- The selected dogs are randomly assigned to one of two groups: a study group or a control group.Merck, Epidemiology
- The study group receives the intervention being evaluated.Merck, Epidemiology
- The control group does not receive the intervention being evaluated.Merck, Epidemiology
- Blinding (or masking) may be used so that certain people involved in the study do not know which dogs are assigned to which group, helping reduce potential bias.Merck, Epidemiology
Conducting large randomized controlled trials in veterinary medicine can be challenging because of the logistical, financial, and time demands involved. However, evidence from smaller randomized controlled trials can still be valuable, especially when results from similar studies contribute to a broader body of research.Weese et al.
Limitations of Small Sample Sizes
Sample size refers to the number of dogs included in a study. Many studies involving canine HCC include a relatively small number of dogs.
Smaller sample sizes may:
- limit a study’s ability to detect differences in the effects of an intervention.Tan et al.
- make it more difficult to determine whether a small association or no association is present.O'Connor et al., 2016
- result in greater uncertainty around study findings.O'Connor et al., 2016
- lead to more extreme results.Jeffery et al.
Small studies can still provide valuable data.Weese et al. But when reading a small study, it is important to keep the limitations of its sample size in mind.
What “Median Survival Time” Means
A commonly reported statistic in veterinary oncology studies is median survival time.
Median survival time refers to the point at which half of the dogs in the study have died and half remain alive.Merck, Survival Analysis
It is important to understand that:
- median survival time is not the same as average (mean) survival timeIntile
- it does not predict how long an individual dog will livePieper Veterinary
- survival outcomes can vary widely from one dog to anotherPieper Veterinary
Median survival time should be understood in the context of the group of dogs included in a specific study instead of as an expectation for an individual dog.
Putting Survival Times Into Context
Survival times in research studies are measured from a defined starting point. This may be the time of diagnosis, study enrollment, the start of treatment, or another relevant event (such as the date of biopsy). This starting point is sometimes referred to as “time zero.”Delgado et al.
Using a defined starting point provides a consistent way to measure outcomes within a study, but it does not necessarily mean that all dogs were at the same stage of disease when measurement began.
For example, one dog may undergo biopsy early in the course of the disease when the tumor is smaller or more localized, while another may be diagnosed later when the disease is more advanced. Even though both dogs are measured from the time of biopsy, their disease may have been at very different stages at that point.
Because of this, survival times can sometimes appear longer simply because measurement started earlier in the disease process. This is known as lead-time bias, where earlier detection can make measured survival appear longer even when the course of the disease has not changed.NCI, Lead Time Bias
It's important to keep in mind differences in the starting points used to measure survival and where dogs were in the course of their disease when measurement began, as these differences can make direct comparisons of survival times between individual dogs or across different studies difficult.
Putting Treatment Outcomes Into Context
Dogs included in a study, or in different treatment groups within a study, may vary in important ways, such as:
- tumor size and extent within the liver
- whether the tumor is surgically resectable
- overall health and presence of other medical conditions
- age and general condition at the time of diagnosis
These differences are worth keeping in mind when comparing outcomes between groups.
One consideration is confounding (literally, "confusion of effects"). When another factor is associated with both the exposure (for example, treatment) and the outcome being studied, the observed relationship between the exposure and outcome cannot necessarily be interpreted as causal.O'Connor et al.
Another consideration is cointerventions. Dogs within the same study may also receive additional treatments or procedures (cointerventions), such as tumor debulking. Differences in cointerventions between groups can introduce bias into study results.Moutzouri et al. When multiple interventions could contribute to an outcome, it may be difficult to determine how much of that outcome is associated with the treatment being studied.
When reading about survival times or treatment outcomes, the characteristics of the dogs included in the study, the characteristics of their tumors, and the treatments or procedures they received can all provide important context. Findings reported in one group of dogs with HCC may not necessarily apply in the same way to every dog with HCC.
Association/Correlation vs. Causation
An association or correlation means that two things are associated or occur together. Causation means that one thing directly causes another.NIH, Association, Causation
For example, a study might find that dogs who underwent surgery had longer survival times. This shows an association between surgery and survival, but it does not by itself establish that surgery caused the difference. Dogs that undergo surgery may differ from other dogs in important ways – such as tumor location, stage of disease, or overall health – that may also be related to survival.
An observed association does not necessarily mean that one factor caused the outcome.
Randomized controlled trials can provide stronger evidence about whether an intervention causes an outcome because randomization can reduce selection bias and help make treatment groups more comparable with respect to factors that could affect prognosis.Moher et al.
As mentioned earlier, these types of studies can be challenging to conduct in veterinary medicine.
What to Keep in Mind When Reading a Study
When reading a study about canine HCC, looking at the details can help put the results into context. Some factors and questions to consider include:
Study Design
What type of study was conducted (such as a case report, case series, cohort study, or randomized controlled trial), and was the data collected prospectively or retrospectively?
Sample Size
How many dogs were included in the study, and how many were included in each group being compared?
Dogs and Tumor Characteristics
Which dogs were included in the study, and what were the characteristics of their tumors, such as subtype, size, or location?
Treatments and Procedures
What treatments or procedures did the dogs receive, and did some dogs receive additional interventions (such as surgical resection or debulking in addition to chemotherapy or a targeted therapy)?
Survival Time
What starting point was used to measure survival – for example, the date of diagnosis, biopsy, or the start of treatment?
Putting Research Into Perspective
Research on canine HCC has limitations, but the available studies still provide valuable information that can help improve our understanding of the disease.
Approaching research with a thoughtful and informed perspective can help you better understand what study findings may – and may not – mean for your dog.
Decisions about your dog’s care should be made together with your veterinary team, who can help interpret research in the context of your dog’s specific situation.
References
- Delgado, Julio, et al. “Survival Analysis in Hematologic Malignancies: Recommendations for Clinicians.” Haematologica, vol. 99, no. 9, 2014, pp. 1410-1420. https://doi.org/10.3324/haematol.2013.100784. [PMC]
- Intile, Joanne Lynn. “Veterinary Medical Jargon Explained.” PetMD, 22 May 2013, https://www.petmd.com/blogs/thedailyvet/jintile/2013/may/veterinary-medical-jargon-explained-30305. Accessed 17 Aug. 2026. [PetMD]
- Jeffery, Nick D., et al. “What Is the Value of Statistical Testing of Observational Data?.” Veterinary Surgery, vol. 51, no. 7, 2022, pp. 1043-1051. https://doi.org/10.1111/vsu.13845. [PMC]
- Merck Veterinary Manual. “Basic Principles of Epidemiology.” Merck Veterinary Manual, Merck & Co., Inc., last updated Sept. 2024, https://www.merckvetmanual.com/public-health/principles-of-epidemiology/basic-principles-of-epidemiology. Accessed 16 Aug. 2026. [Merck]
- Merck Veterinary Manual. “Survival Analysis.” Merck Veterinary Manual, Merck & Co., Inc., last updated Sept. 2024, https://www.merckvetmanual.com/public-health/principles-of-epidemiology/survival-analysis. Accessed 17 Aug. 2026. [Merck]
- Moher, David, et al. “CONSORT 2010 Explanation and Elaboration: Updated Guidelines for Reporting Parallel Group Randomised Trials.” BMJ, vol. 340, 2010, c869. https://doi.org/10.1136/bmj.c869. [BMJ]
- Moutzouri, Elisavet, et al. “Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review.” Journal of the American Heart Association, vol. 9, no. 12, 2020, e014890. https://doi.org/10.1161/JAHA.119.014890. [PMC]
- O'Connor, A. M., et al. “Explanation and Elaboration Document for the STROBE-Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology-Veterinary Extension.” Journal of Veterinary Internal Medicine, vol. 30, no. 6, 2016, pp. 1896-1928. https://doi.org/10.1111/jvim.14592. [PMC]
- National Institutes of Health. “Appendix: Biomedical Definitions.” NIH Style Guide, U.S. Department of Health and Human Services, https://www.nih.gov/nih-style-guide/appendix-biomedical-definitions. Accessed 17 Aug. 2026. [NIH]
- PDQ® Screening and Prevention Editorial Board. “PDQ Cancer Screening Overview.” National Cancer Institute, U.S. Department of Health and Human Services, https://www.cancer.gov/about-cancer/screening/patient-screening-overview-pdq. Accessed 17 Aug. 2026. [NCI]
- Pieper Veterinary. “Oncology FAQs.” Pieper Veterinary, https://pieperveterinary.com/specialty-services/oncology/oncology-faqs/. Accessed 17 Aug. 2026. [Pieper Veterinary]
- Sargeant, Jan M., et al. “What's in a Name? The Incorrect Use of Case Series as a Study Design Label in Studies Involving Dogs and Cats.” Journal of Veterinary Internal Medicine, vol. 31, no. 4, 24 May 2017, pp. 1035-1042. https://doi.org/10.1111/jvim.14741. [PMC]
- Sargeant, Jan M., et al. “The Standards of Reporting Trials in Pets (PetSORT): Explanation and Elaboration.” Frontiers in Veterinary Science, vol. 10, 30 Mar. 2023, 1137781. https://doi.org/10.3389/fvets.2023.1137781. [PMC]
- Tan, Yuan Jin, et al. “An Empirical Assessment of Research Practices across 163 Clinical Trials of Tumor-Bearing Companion Dogs.” Scientific Reports, vol. 9, no. 1, 15 Aug. 2019, 11877. https://doi.org/10.1038/s41598-019-48425-5. [PMC]
- Totton, Sarah C., et al. “What to Call Your Medical Records-Based Study.” Journal of the American Veterinary Medical Association, vol. 263, no. 12, 8 Oct. 2025, pp. 1578-1581. https://doi.org/10.2460/javma.25.06.0425. [PubMed]
- Weese, J. S., et al. “Small Sample Sizes in Clinical Trials: A Pragmatic Approach to Clinical Research in Veterinary Medicine.” The Journal of Small Animal Practice, vol. 67, no. 4, 2026, pp. 299-301. https://doi.org/10.1111/jsap.70063. [PMC]